Fresh 3D Printing of Spanlastics Hydrogel for Drug Delivery Applications In Vitro
Pharmaceutical Research · 2026
DOI: 10.1007/s11095-026-04068-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Elom Doe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Engineering and 3D Printing Lab (PharmE3D), Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississip…. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Doxorubicin, Hydrogels, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To develop a localized delivery implant by integrating doxorubicin loaded spanlastic vesicles within Freeform Reversible Embedding of Suspended Hydrogels (FRESH) printed alginate constructs.
Methods
Spanlastics composed of Sorbitan Monostearate (Span60) and an edge activator, Polyethylene sorbitol ester (Tween 80), were prepared by ethanolic injection. Plain and drug-loaded spanlastics were characterized for their physicochemical properties. Vesicles were incorporated into 3D printed sodium alginate hydrogels in ‘FRESH’ bioprinting process to promote the sustained drug release of doxorubicin which was assessed using dialysis membrane for drug release. In vitro uptake and cytotoxicity were evaluated in MCF7 breast cancer cells.
Results
Optimized formulations produced vesicles of approximately 200 to 300 nm with moderate encapsulation efficiency (33 to 44%) and stability during hydrogel incorporation and printing. Printed depots provided sustained doxorubicin release relative to suspension and reduced MCF7 viability, with preferential intracellular and nuclear localization consistent with doxorubicin activity.
Conclusion
Spanlastic-loaded FRESH printed alginate implants combine vesicle-mediated cellular delivery with matrix-governed sustained release, supporting their potential as a localized chemotherapy depot for further in vivo validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Engineering and 3D Printing Lab (PharmE3D), Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 1 University Avenue, University, MS, 38677, USA.
- Department of Chemical and Biomolecular Engineering, University of Maryland, College Park, MD, 20742, USA.
- Pharmaceutical Engineering and 3D Printing Lab (PharmE3D), Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 1 University Avenue, University, MS, 38677, USA. mmaniruz@olemiss.…
Zitieren
APA
Doe, E., Alabi, A., Chakka, L. R. J., & Maniruzzaman, M. (2026). Fresh 3D Printing of Spanlastics Hydrogel for Drug Delivery Applications In Vitro. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04068-6
Vancouver
Doe E, Alabi A, Chakka LRJ, Maniruzzaman M. Fresh 3D Printing of Spanlastics Hydrogel for Drug Delivery Applications In Vitro. Pharmaceutical Research. 2026. doi:10.1007/s11095-026-04068-6
BibTeX
@article{Doe2026,
author = {Doe, Elom and Alabi, Abigail and Chakka, Leela Raghava Jaidev and Maniruzzaman, Mohammed},
title = {Fresh 3D Printing of Spanlastics Hydrogel for Drug Delivery Applications In Vitro},
journal = {Pharmaceutical Research},
year = {2026},
doi = {10.1007/s11095-026-04068-6}
}
EUVIMED